NOVO NORDISK A/S Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 902,6 DKK | +2,01% |
|
+3,12% | +29,29% |
| 17:01 | FTC vecht 'rommelige' octrooilijsten aan voor Ozempic, Victoza, andere medicijnen | MT |
| 29/04 | Eén dosis Wegovy van Novo Nordisk weer in voorraad, toont website FDA | RE |
Officiële publicaties
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Slide show Q3 | CO | |
| 3rd quarter report | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Share buyback | CO | |
| Slide show half-year results | CO | |
| Half-year report | CO |
Headlines
- Beurs
- Aandelen
- Koers NOVO B
- Nieuws Novo Nordisk A/S
- Officiële publicaties
